Junji Shibahara

7.7k total citations · 3 hit papers
152 papers, 4.7k citations indexed

About

Junji Shibahara is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Junji Shibahara has authored 152 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Surgery, 48 papers in Oncology and 36 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Junji Shibahara's work include Pancreatic and Hepatic Oncology Research (20 papers), Glioma Diagnosis and Treatment (19 papers) and Hepatocellular Carcinoma Treatment and Prognosis (17 papers). Junji Shibahara is often cited by papers focused on Pancreatic and Hepatic Oncology Research (20 papers), Glioma Diagnosis and Treatment (19 papers) and Hepatocellular Carcinoma Treatment and Prognosis (17 papers). Junji Shibahara collaborates with scholars based in Japan, United States and India. Junji Shibahara's co-authors include Masashi Fukayama, Norihiro Kokudo, Kiyoshi Hasegawa, Tomoki Todo, Takeaki Ishizawa, Minoru Tanaka, Yasushi Ino, Koichi Masuda, Noriyoshi Fukushima and Hiroyuki Aburatani and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Junji Shibahara

141 papers receiving 4.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Real‐time identification of liver cancers by using indocyanine green fluorescent imaging

2009 624 citations Junji Shibahara, Kiyoshi Hasegawa et al. profile →
Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial

2022 317 citations Tomoki Todo, Hirotaka Ito et al. Nature Medicine profile →
A phase I/II study of triple-mutated oncolytic herpes virus G47∆ in patients with progressive glioblastoma

2022 135 citations Tomoki Todo, Yasushi Ino et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junji Shibahara Japan	37	1.3k	1.3k	1.2k	948	730	152	4.7k
Bi‐Sen Ding United States	37	754 0.6×	2.9k 2.3×	1.2k 1.0×	1.1k 1.2×	780 1.1×	74	6.4k
Chang Ohk Sung South Korea	33	1.8k 1.3×	1.4k 1.1×	749 0.6×	838 0.9×	379 0.5×	142	4.0k
Jason Chia‐Hsien Cheng Taiwan	37	1.0k 0.8×	859 0.7×	1.2k 1.0×	1.4k 1.5×	562 0.8×	208	4.5k
Daniela Campani Italy	38	2.0k 1.5×	1.4k 1.1×	1.3k 1.1×	660 0.7×	772 1.1×	176	4.8k
Thomas Brunner Germany	43	2.9k 2.2×	1.5k 1.2×	1.5k 1.2×	1.9k 2.0×	658 0.9×	170	5.9k
Maximilian Bockhorn Germany	39	2.1k 1.6×	1.1k 0.8×	1.3k 1.0×	967 1.0×	491 0.7×	150	4.0k
Kazuhiko Ogawa Japan	39	1.3k 1.0×	1.2k 1.0×	1.2k 1.0×	2.0k 2.2×	861 1.2×	320	5.7k
Guido Coggi Italy	39	1.6k 1.2×	1.7k 1.4×	825 0.7×	854 0.9×	575 0.8×	102	4.4k
Penelope Brock United Kingdom	34	1.6k 1.2×	1.4k 1.1×	1.1k 0.9×	782 0.8×	692 0.9×	93	4.9k
Alexander Quaas Germany	36	2.1k 1.6×	1.1k 0.9×	1.0k 0.9×	1.2k 1.2×	726 1.0×	227	4.8k

Countries citing papers authored by Junji Shibahara

Since Specialization

Citations

This map shows the geographic impact of Junji Shibahara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Shibahara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Shibahara more than expected).

Fields of papers citing papers by Junji Shibahara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Shibahara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Shibahara. The network helps show where Junji Shibahara may publish in the future.

Co-authorship network of co-authors of Junji Shibahara

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Shibahara. A scholar is included among the top collaborators of Junji Shibahara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Shibahara. Junji Shibahara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanaka, Ryota, Kohei Hashimoto, Keisei Tachibana, et al.. (2024). Artificial Intelligence Recognition Model Using Liquid-Based Cytology Images to Discriminate Malignancy and Histological Types of Non-Small-Cell Lung Cancer. Pathobiology. 92(1). 1–11. 2 indexed citations

Sekino, Yuta, Yukihiko Sonoda, Ichiyo Shibahara, et al.. (2024). Protocol digest of a phase III randomized trial of gross total resection versus possible resection of fluid-attenuated inversion recovery-hyperintense lesion on MRI for newly diagnosed supratentorial glioblastoma: JCOG2209 (FLAMINGO). Japanese Journal of Clinical Oncology. 55(1). 75–79.

Shibayama, Takahiro, Akimasa Hayashi, Yu-Jui Ho, et al.. (2024). Combination immunohistochemistry for CK5/6, p63, GATA6, and HNF4a predicts clinical outcome in treatment-naïve pancreatic ductal adenocarcinoma. Scientific Reports. 14(1). 15598–15598. 2 indexed citations

Tanaka, Ryota, Masachika Fujiwara, Hitomi Kanno, et al.. (2023). Cytological characteristics of histological types of lung cancer by cytomorphometric and flow cytometric analyses using liquid‐based cytology materials. Diagnostic Cytopathology. 51(6). 356–364. 2 indexed citations

Saito, Yuri A., et al.. (2023). Endoscopic submucosal dissection for adenoma in gastric adenocarcinoma and proximal polyposis of the stomach. Endoscopy. 55(S 01). E928–E929. 2 indexed citations

Sasaki, Nobuyoshi, Makoto Kobayashi, Kuniaki Saito, et al.. (2023). 10221-ML-11 A CASE OF PRIMARY CENTRAL NERVOUS SYSTEM ADULT T CELL LEUKEMIA. Neuro-Oncology Advances. 5(Supplement_5). v22–v22.

Sasagawa, Shota, Hiroaki Kato, Todd A. Johnson, et al.. (2023). Immuno-genomic analysis reveals eosinophilic feature and favorable prognosis of female non-smoking esophageal squamous cell carcinomas. Cancer Letters. 581. 216499–216499. 8 indexed citations

Todo, Tomoki, Hirotaka Ito, Yasushi Ino, et al.. (2022). Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial. Nature Medicine. 28(8). 1630–1639. 317 indexed citations breakdown →

Makise, Naohiro, Taisuke Mori, Toru Motoi, et al.. (2020). Recurrent FOS rearrangement in proliferative fasciitis/proliferative myositis. Modern Pathology. 34(5). 942–950. 9 indexed citations

10.

Nagahama, Kiyotaka, et al.. (2020). Membranous nephropathy with masked polyclonal IgG deposits associated with primary Sjögren’s syndrome. CEN Case Reports. 10(1). 53–58. 2 indexed citations

11.

Kishino, Tomonori, Takeshi Morii, Satsuki Matsushima, et al.. (2020). Discrimination of well-differentiated liposarcoma from benign lipoma on sonography: an uncontrolled retrospective study. Journal of Medical Ultrasonics. 47(4). 617–623. 8 indexed citations

12.

Tanaka, Kei, Kiyotaka Nagahama, Shinji Tanigaki, et al.. (2020). Mirror syndrome due to anti-Jra alloimmunization. Taiwanese Journal of Obstetrics and Gynecology. 59(3). 456–459. 2 indexed citations

13.

Funata, Sayaka, Kiyotaka Nagahama, Kazunobu Isogaya, et al.. (2019). DNMT3A overexpression is associated with aggressive behavior and enteroblastic differentiation of gastric adenocarcinoma. Annals of Diagnostic Pathology. 44. 151456–151456. 15 indexed citations

14.

Okuda, Kenichi, Akihisa Mitani, Yasuhiro Yamauchi, et al.. (2017). A case of delayed exacerbation of interstitial lung disease after discontinuation of temsirolimus. Respiratory Medicine Case Reports. 22. 158–163. 1 indexed citations

15.

Mukasa, Akitake, Kuniaki Saito, Shota Tanaka, et al.. (2016). Successful treatment of mixed yolk sac tumor and mature teratoma in the spinal cord: case report. Journal of Neurosurgery Spine. 26(3). 319–324. 7 indexed citations

16.

Hayashi, Akimasa, Junji Shibahara, Kento Misumi, et al.. (2016). Histologic Assessment of Intratumoral Lymphoplasmacytic Infiltration Is Useful in Predicting Prognosis of Patients with Hepatocellular Carcinoma. PLoS ONE. 11(5). e0155744–e0155744. 8 indexed citations

17.

Koga, Tomoyuki, Akio Morita, Keisuke Maruyama, et al.. (2009). Long-term control of disseminated pleomorphic xanthoastrocytoma with anaplastic features by means of stereotactic irradiation. Neuro-Oncology. 11(4). 446–451. 43 indexed citations

18.

Tanaka, Yuko, Hideaki Yokoo, Takashi Komori, et al.. (2005). A distinct pattern of Olig2-positive cellular distribution in papillary glioneuronal tumors: a manifestation of the oligodendroglial phenotype?. Acta Neuropathologica. 110(1). 39–47. 42 indexed citations

19.

Fukumoto, Shinichi, Naoko Yamauchi, Hisashi Moriguchi, et al.. (2005). Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non–Small Cell Lung Carcinomas. Clinical Cancer Research. 11(5). 1776–1785. 250 indexed citations

20.

Sakuma, Kazuya, Ja‐Mun Chong, Makoto Sudo, et al.. (2004). High‐density methylation of p14^ARF and p16^INK4A in Epstein‐Barr virus–associated gastric carcinoma. International Journal of Cancer. 112(2). 273–278. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact